Experiment | Aim | Objective type | Objective target | Performance measure |
---|---|---|---|---|
1 | Compare REINVENT and AHC for varying values of σ | Docking | DRD2 | Docking score & uniqueness |
2 | Compare REINVENT and AHC against different target systems | Docking | DRD2 | Docking score & uniqueness |
Docking | OPRM1 | Docking score & uniqueness | ||
Docking | AGTR1 | Docking score & uniqueness | ||
Docking | OX1R | Docking score & uniqueness | ||
3 | Investigate and identify optimal DF and respective parameters for use with AHC | Similarity | Aripiprazole | Tanimoto similarity, uniqueness & wall time |
Isomer | C11H24 | Isomer score, uniqueness & wall time | ||
Similarity & PhysChem (MPO) | Osimertinib | MPO score, uniqueness & wall time | ||
4Â & 5 | Benchmark AHC to other commonly used RL strategies | PhysChem | Heavy atoms | # Heavy atoms, validity, uniqueness & wall time |
Similarity | Risperidone | Tanimoto similarity, validity, uniqueness & wall time | ||
Activity | DRD2 | Predicted activity, validity, uniqueness & wall time | ||
Docking | DRD2 | Docking score, validity, uniqueness & wall time | ||
Dual activity (MPO) | DRD2 & DRD3 | Average predicted activity, validity, uniqueness & wall time | ||
Selectivity (MPO) | DRD2 > DRD3 | Average predicted activity, validity, uniqueness & wall time |